A detailed history of Envestnet Asset Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Envestnet Asset Management Inc holds 10,021,217 shares of PFE stock, worth $280 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
10,021,217
Previous 8,029,680 24.8%
Holding current value
$280 Million
Previous $231 Million 20.29%
% of portfolio
0.11%
Previous 0.1%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$25.89 - $29.73 $51.6 Million - $59.2 Million
1,991,537 Added 24.8%
10,021,217 $278 Million
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $6.47 Million - $8.4 Million
-247,627 Reduced 2.99%
8,029,680 $231 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $46.1 Million - $53.9 Million
1,437,300 Added 21.01%
8,277,307 $275 Million
Q2 2023

Aug 04, 2023

SELL
$36.12 - $41.79 $42.4 Million - $49.1 Million
-1,174,642 Reduced 14.66%
6,840,007 $251 Million
Q1 2023

May 11, 2023

BUY
$39.39 - $51.28 $84.3 Million - $110 Million
2,140,952 Added 36.45%
8,014,649 $327 Million
Q4 2022

Feb 07, 2023

SELL
$41.75 - $54.5 $15.9 Million - $20.8 Million
-381,842 Reduced 6.1%
5,873,697 $301 Million
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $17.7 Million - $21.6 Million
403,638 Added 6.9%
6,255,539 $274 Million
Q2 2022

Aug 03, 2022

BUY
$46.53 - $55.17 $56.2 Million - $66.6 Million
1,206,759 Added 25.98%
5,851,901 $307 Million
Q1 2022

May 04, 2022

BUY
$45.75 - $56.69 $9.63 Million - $11.9 Million
210,582 Added 4.75%
4,645,142 $240 Million
Q4 2021

Feb 04, 2022

SELL
$41.32 - $61.25 $21.6 Million - $32 Million
-523,015 Reduced 10.55%
4,434,560 $262 Million
Q3 2021

Oct 07, 2021

SELL
$39.25 - $50.42 $14 Million - $18 Million
-356,096 Reduced 6.7%
4,957,575 $213 Million
Q2 2021

Aug 04, 2021

BUY
$35.91 - $40.68 $15.1 Million - $17.2 Million
421,711 Added 8.62%
5,313,671 $208 Million
Q1 2021

May 04, 2021

BUY
$33.49 - $37.77 $15 Million - $17 Million
448,943 Added 10.1%
4,891,960 $177 Million
Q4 2020

Feb 02, 2021

SELL
$33.47 - $42.56 $2.1 Million - $2.67 Million
-62,758 Reduced 1.39%
4,443,017 $164 Million
Q3 2020

Oct 09, 2020

BUY
$31.75 - $37.25 $755,808 - $886,736
23,805 Added 0.53%
4,505,775 $165 Million
Q2 2020

Jul 08, 2020

SELL
$30.12 - $36.54 $5.77 Million - $7 Million
-191,554 Reduced 4.1%
4,481,970 $147 Million
Q1 2020

Apr 23, 2020

BUY
$27.03 - $38.62 $20.4 Million - $29.1 Million
754,250 Added 19.24%
4,673,524 $153 Million
Q4 2019

Feb 11, 2020

BUY
$32.92 - $37.36 $23.4 Million - $26.5 Million
710,099 Added 22.13%
3,919,274 $154 Million
Q3 2019

Oct 17, 2019

BUY
$32.49 - $42.13 $5.49 Million - $7.12 Million
168,957 Added 5.56%
3,209,175 $115 Million
Q2 2019

Aug 02, 2019

BUY
$36.98 - $41.52 $7.3 Million - $8.19 Million
197,292 Added 6.94%
3,040,218 $132 Million
Q1 2019

May 10, 2019

BUY
$37.5 - $41.2 $3.71 Million - $4.08 Million
99,000 Added 3.61%
2,842,926 $121 Million
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $103 Million - $117 Million
2,669,402 Added 3581.94%
2,743,926 $120 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $14.2 Million - $17.2 Million
-412,320 Reduced 84.69%
74,524 $3.28 Million
Q2 2018

Aug 10, 2018

BUY
$32.98 - $35.16 $642,879 - $685,373
19,493 Added 4.17%
486,844 $17.7 Million
Q1 2018

May 09, 2018

SELL
$31.91 - $37.02 $19.8 Million - $22.9 Million
-619,535 Reduced 57.0%
467,351 $16.5 Million
Q4 2017

Feb 20, 2018

BUY
$33.26 - $35.29 $3.41 Million - $3.62 Million
102,521 Added 10.41%
1,086,886 $39.4 Million
Q3 2017

Nov 13, 2017

SELL
$31.0 - $34.15 $2.51 Million - $2.77 Million
-81,030 Reduced 7.61%
984,365 $35.1 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,065,395
1,065,395 $35.8 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.